COX-1 upregulation results have also been reported in studies using real-time PCR to measure COX-1 mRNA, with [15] and without [16] statistically significant differences between nasal polyps from patients with AERD and non-AERD compared to nasal mucosa controls. The gene discussed is PTGS1; the disease is nasal cavity polyp.